Delving into the Latest Updates on Trophea Development Ab with Synapse

概览

关联

1

项与 Trophea Development Ab 相关的药物

NANT Colorectal Cancer Vaccine containing nivolumab(ImmunityBio)

靶点

PD-1

作用机制

PD-1抑制剂

在研机构-

原研机构

ImmunityBio, Inc.

在研适应症-

非在研适应症

结直肠癌

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

1

项与 Trophea Development Ab 相关的临床试验

NCT03783988 / Unknown status临床1期

An Open, Uncontrolled Pharmacokinetic Study With a New Topical Combination Gel Containing Triiodothyroacetic Acid (TRIAC) and Dehydroepiandrosterone (DHEA) in Subjects With Skin Atrophy Due to Topical Treatment With Glucocorticoids

An open, uncontrolled pharmacokinetic study with a new topical combination gel containing triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA) in subjects with skin atrophy due to topical treatment with glucocorticoids.

开始日期2019-01-15

申办/合作机构

Trophea Development Ab

[+1]

100 项与 Trophea Development Ab 相关的临床结果

登录后查看更多信息

0 项与 Trophea Development Ab 相关的专利（医药）

登录后查看更多信息

100 项与 Trophea Development Ab 相关的药物交易

登录后查看更多信息

100 项与 Trophea Development Ab 相关的转化医学

登录后查看更多信息